Aspirin-induced, HDAC-modulated, regulation of endothelial function and vascular
Aspirin-induced, HDAC-modulated, regulation of endothelial function and vascular
批准号:
8063361
负责人:
Kaikobad J. Irani
金额:
$18.94万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-02-04 至 2013-01-31
关键词:
AcetylationAspirinAttentionBlood ClotBlood PlateletsBlood PressureBlood VesselsBlood coagulationCalmodulinCardiovascular DiseasesCardiovascular systemCellsChemicalsClinical TreatmentClinical TrialsDeacetylaseDoseEndotheliumEventFigs - dietaryFutureHistone DeacetylaseHistone Deacetylase InhibitorLysineMalignant NeoplasmsMediatingMolecularMyocardial InfarctionNitric OxideNitric Oxide SynthasePatientsPharmacologic SubstancePhysiologicalPlatelet ActivationPlatelet Aggregation InhibitionPlatelet aggregationPost-Translational Protein ProcessingPreventionProductionPropertyProteinsRegulationResearchResistanceRisk FactorsRoleSecondary PreventionSerineStrokeTestingTherapeuticThromboxane A2Vascular DiseasesVascular Endothelium-Dependent RelaxationVasoconstrictor AgentsVasodilationacute coronary syndromebasecardiovascular disorder preventioncardiovascular risk factorcyclooxygenase 1designexperienceheart disease preventionhigh riskhistone deacetylase 3human NOS3 proteinimprovedinhibitor/antagonistlysyllysinenovelpreventtool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Low-dose acetylsalicylic acid (aspirin) is widely used in the treatment and prevention of vascular disease. Aspirin prevents platelet activation and aggregation, but is also known to have platelet-independent vasoprotective effects. Aspirin promotes endothelium- dependent vasorelaxation but mechanisms by which it does so are not completely understood. The principal hypothesis of this application is that reversible acetylation of lysine residues in endothelial nitric oxide synthase (eNOS) by low-dose aspirin stimulates eNOS activity, and promotes endothelium-dependent vascular relaxation. The novelty of this application lies in 1) determining the role of lysine acetylation of eNOS by low-dose aspirin as a post-translational modification that promotes eNOS enzymatic activity and thereby endothelial NO production, and 2) exploring the role of the endogenous lysine deacetylase, histone deacetylase-3 (HDAC3), in reversing aspirin- stimulated lysine acetylation of eNOS and thereby antagonizing aspirin-induced endothelial NO production. The significance of this proposal lies in 1) identifying a novel molecular mechanism through which cardiovascular doses of aspirin may have vasoprotective effects, and 2) identifying a potentially exploitable endogenous mechanism that antagonizes the effect of aspirin on the vasculature. Although low-dose aspirin is effective in the prevention and treatment of cardiovascular disease, a significant proportion of patients on aspirin experience atherothrombotic events, underscoring the importance of further understanding how aspirin functions in the vasculature. This application, by looking at lysine acetylation of eNOS as a new mechanism for the effect of low-dose aspirin on endothelial function, and by identifying an endogenous antagonist to aspirin in the endothelium, may pave the way for future strategies that better harness the therapeutic potential of this widely used pharmaceutical.
PUBLIC HEALTH RELEVANCE: Aspirin is widely used for the treatment and prevention of heart disease and has many beneficial effects on blood vessels. This research will explore whether aspirin chemically modifies nitric oxide synthase, a protein in blood vessels that improves vessel function and inhibits blood clot formation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The SIRT1-Gpd1L-NAD+ interactome in regulation of the Neuronal Sodium Channel: Implications for Cognitive Impairment of Alzheimerâs Dementia
-
批准号:10117944
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2019
-
负责人:Kaikobad J. Irani
-
依托单位:
SIRTUIN1-mediated inhibition of p66shc lysine acetylation as a novel treatment for diabetic vasculopathy
-
批准号:9272262
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:Kaikobad J. Irani
-
依托单位:
Nexus between miR-204, gut microbiome, and aortic aneurysmal disease
-
批准号:10009809
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:Kaikobad J. Irani
-
依托单位:
SIRTUIN1-mediated inhibition of p66shc lysine acetylation as a novel treatment for diabetic vasculopathy
-
批准号:9135028
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:Kaikobad J. Irani
-
依托单位:
Nexus between miR-204, gut microbiome, and aortic aneurysmal disease
-
批准号:10201510
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:Kaikobad J. Irani
-
依托单位:
Regulation of the Cardiac Sodium Channel by SIRTUIN1
-
批准号:8531474
-
项目类别:
-
资助金额:$61.17万
-
财政年份:2013
-
负责人:Kaikobad J. Irani
-
依托单位:
Regulation of the Cardiac Sodium Channel by Sumoylation
-
批准号:10680501
-
项目类别:
-
资助金额:$63.67万
-
财政年份:2013
-
负责人:Kaikobad J. Irani
-
依托单位:
Regulation of the Cardiac Sodium Channel by Sumoylation
-
批准号:10449203
-
项目类别:
-
资助金额:$63.67万
-
财政年份:2013
-
负责人:Kaikobad J. Irani
-
依托单位:
Regulation of the Cardiac Sodium Channel by SIRTUIN1
-
批准号:8670568
-
项目类别:
-
资助金额:$61.15万
-
财政年份:2013
-
负责人:Kaikobad J. Irani
-
依托单位:
Regulation of the Cardiac Sodium Channel by Sumoylation
-
批准号:10058155
-
项目类别:
-
资助金额:$68.25万
-
财政年份:2013
-
负责人:Kaikobad J. Irani
-
依托单位:
Aspirin and HDAC regulation of endothelial function and vascular tone
-
批准号:8730359
-
项目类别:
-
资助金额:$10.44万
-
财政年份:2011
-
负责人:Kaikobad J. Irani
-
依托单位:
Aspirin and HDAC regulation of endothelial function and vascular tone
-
批准号:8220820
-
项目类别:
-
资助金额:$12.28万
-
财政年份:2011
-
负责人:Kaikobad J. Irani
-
依托单位:
Transcriptional and Epigenetic regulation of P66shc: relevance to endothelial fun
-
批准号:7573084
-
项目类别:
-
资助金额:$37.88万
-
财政年份:2009
-
负责人:Kaikobad J. Irani
-
依托单位:
Transcriptional and Epigenetic regulation of P66shc: relevance to endothelial fun
-
批准号:7851336
-
项目类别:
-
资助金额:$37.88万
-
财政年份:2009
-
负责人:Kaikobad J. Irani
-
依托单位:
Core--Viral
-
批准号:6803073
-
项目类别:
-
资助金额:$29.71万
-
财政年份:2003
-
负责人:Kaikobad J. Irani
-
依托单位:
Functions and Mechanisms of Ref-1 in the Endothlium
-
批准号:7061514
-
项目类别:
-
资助金额:$22.79万
-
财政年份:2002
-
负责人:Kaikobad J. Irani
-
依托单位:
Functions and Mechanisms of Ref-1 in the Endothlium
-
批准号:6776950
-
项目类别:
-
资助金额:$18.08万
-
财政年份:2002
-
负责人:Kaikobad J. Irani
-
依托单位:
Redox-and acetylation-dependent control of vascular tone
-
批准号:8069234
-
项目类别:
-
资助金额:$24.35万
-
财政年份:2002
-
负责人:Kaikobad J. Irani
-
依托单位:
Redox-and acetylation-dependent control of vascular tone
-
批准号:7806369
-
项目类别:
-
资助金额:$34.09万
-
财政年份:2002
-
负责人:Kaikobad J. Irani
-
依托单位:
Functions and Mechanisms of Ref-1 in the Endothlium
-
批准号:6612586
-
项目类别:
-
资助金额:$40.88万
-
财政年份:2002
-
负责人:Kaikobad J. Irani
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Aspirin调控AKT/Foxo3a/BIM通路延缓吡咯替尼耐药作用机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:田武国
-
依托单位:
Aspirin与自噬通路及核转录因子FoxG1在听觉系统退行性变中的协同调控机制研究
-
批准号:81800915
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:贺祖宏
-
依托单位:
Aspirin联合牙周膜干细胞再生全脱位牙牙周组织机制研究
-
批准号:81760190
-
项目类别:地区科学基金项目
-
资助金额:32.0万元
-
批准年份:2017
-
负责人:王璇
-
依托单位:
可注射温敏型水凝胶缓释Aspirin碳点和EPO促牙周组织再生的研究
-
批准号:81600879
-
项目类别:青年科学基金项目
-
资助金额:17.0万元
-
批准年份:2016
-
负责人:徐晓薇
-
依托单位:
Aspirin协同IFN-α抑制肝癌转移复发的作用及机制研究
-
批准号:30972889
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2009
-
负责人:智绪亭
-
依托单位:
胃癌microRNA特异表达与靶基因调控及Aspirin的作用
-
批准号:30873099
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2008
-
负责人:王雪融
-
依托单位: